AS-116: Role of Transesophageal Echocardiography in the Hybrid Approach to Perventricular Device Closure of Muscular Ventricular Septal Defects

Abstract Background: This report presents updated data and mid-term follow-up information to a former study introducing the novel technique of percutaneous-perventricular device closure of doubly committed subarterial ventricular septal defect. Methods: Thirty-eight patients were added to the former series. There were 54 patients in total who had isolated doubly committed subarterial ventricular septal defects and underwent percutaneous-perventricular device closure. Closure outcomes and possible complications were measured in the hospital and during the 2.5-year follow-up. Results: Surgery was successful in 53 patients (98.1%). There was no death, residual shunt, new valve regurgitation or arrhythmia either perioperatively or during the entire follow-up period. Only one patient developed pericardial effusion and tamponade in the former series. The mean hospital stay was 3.2±0.6 days (range, 3.0 to 6.0 days), and only one unsuccessful case needed blood transfusion (1.9%). Conclusions: The percutaneous-perventricular device closure of isolated doubly committed subarterial ventricular septal defects appeared to be safe. Close monitoring for bleeding is essential postoperatively, especially in younger patients. This technique is generally safe with acceptable mid-term follow-up.

Download Full-text

Multicenter Experience with Perventricular Device Closure of Muscular Ventricular Septal Defects

Pediatric Cardiology ◽

10.1007/s00246-004-0956-2 ◽

2005 ◽

Vol 26 (2) ◽

pp. 169-175 ◽

Cited By ~ 100

Author(s):

E.A. Bacha ◽

Q.-L. Cao ◽

M.E. Galantowicz ◽

J.P. Cheatham ◽

C.E. Fleishman ◽

...

Keyword(s):

Ventricular Septal Defects ◽

Device Closure ◽

Septal Defects ◽

Perventricular Device Closure

Download Full-text

The role of intraoperative device closure in the management of muscular ventricular septal defects

Seminars in Thoracic and Cardiovascular Surgery Pediatric Cardiac Surgery Annual ◽

10.1016/s1092-9126(03)70011-8 ◽

2003 ◽

Vol 6 (1) ◽

pp. 84-89 ◽

Cited By ~ 5

Author(s):

Igor E. Konstantinov ◽

John G. Coles

Keyword(s):

Ventricular Septal Defects ◽

Device Closure ◽

Septal Defects

Download Full-text

Percutaneous-perventricular device closure of ventricular septal defect: mid-term follow-up.

10.21203/rs.2.16046/v3 ◽

2020 ◽

Author(s):

Long Wang ◽

Lin Xie ◽

Weiqiang Ruan ◽

Tao Li ◽

Changping Gan ◽

...

Keyword(s):

Ventricular Septal Defect ◽

Septal Defect ◽

Close Monitoring ◽

The Novel ◽

Ventricular Septal Defects ◽

Device Closure ◽

Residual Shunt ◽

Septal Defects ◽

Perventricular Device Closure

Abstract Background: This report presents updated data and mid-term follow-up information to a former study introducing the novel technique of percutaneous-perventricular device closure of doubly committed subarterial ventricular septal defect. Methods: Thirty-eight patients were added to the former series. There were 54 patients in total who had isolated doubly committed subarterial ventricular septal defects and underwent percutaneous-perventricular device closure. Closure outcomes and possible complications were measured in the hospital and during the 2.5-year follow-up. Results: Surgery was successful in 53 patients (98.1%). There was no death, residual shunt, new valve regurgitation or arrhythmia either perioperatively or during the entire follow-up period. Only one patient developed pericardial effusion and tamponade in the former series. The mean hospital stay was 3.2±0.6 days (range, 3.0 to 6.0 days), and only one unsuccessful case needed blood transfusion (1.9%). Conclusions: The percutaneous-perventricular device closure of isolated doubly committed subarterial ventricular septal defects appeared to be safe. Close monitoring for bleeding is essential postoperatively, especially in younger patients. This technique is generally safe with acceptable mid-term follow-up.

Download Full-text

Value of transesophageal echocardiography in device closure of perimembranous ventricular septal defects in children via an ultraminimal intercostal incision

10.22541/au.163275137.78829535/v1 ◽

2021 ◽

Author(s):

Jin Yu ◽

Jing Ye ◽

Zewei Zhang ◽

Xiuzhen Yang ◽

Lianglong Ma ◽

...

Keyword(s):

Transesophageal Echocardiography ◽

Septal Defect ◽

Perioperative Period ◽

Ventricular Septal Defects ◽

Device Closure ◽

Efficacy Evaluation ◽

Puncture Site ◽

Septal Defects ◽

Perimembranous Ventricular Septal Defect

Object: Investigate the value of transesophageal echocardiography (TEE) in perimembranous ventricular septal defect (PmVSD) closure via a left parasternal ultra‐minimal trans intercostal incision in children. Methods: From January 2015 and December 2020, 212 children with PmVSD were performed device occlusion via an ultraminimal intercostal incision. TEE is used throughout the perioperative period, including TEE assessment, TEE-guided localization of the puncture site, TEE guidance. All patients were followed up using transthoracic echocardiography for over 6 months. Results: A total of 207 cases successfully occluded, the successful rate was 97. 64%. one hundred and forty-five patients had single orifice, and 62 patients had multiple orifices in the AMS. During the operation, the surgeon readjusted the device or replaced the larger device in 17 cases. After operation, there were 19 cases of slight residual shunts, 13 cases of pericardial effusion and 4 cases of pleural effusion. And all were back to normal during the 4- month follow-up period. Mild mitral regurgitation was presented in 1 patient and remained the same during the follow-up period. No other complications were found. Conclusions: TEE was used to evaluate and determine the defect in PmVSDs with an concentric occluder via a left parasternal ultra‐minimal trans intercostal incision. TEE guidance and immediate postoperative efficacy evaluation are of great value, which can effectively guide the treatment of PmVSD occlusion.

Download Full-text